Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3069.79 | 180 / 180 | 99% | 59.43 | 425 / 430 |
thymus | 99% | 1388.22 | 644 / 653 | 99% | 65.71 | 601 / 605 |
skin | 99% | 2627.30 | 1794 / 1809 | 99% | 142.07 | 466 / 472 |
adrenal gland | 100% | 4742.30 | 258 / 258 | 97% | 54.49 | 222 / 230 |
uterus | 100% | 3033.95 | 170 / 170 | 96% | 81.91 | 441 / 459 |
bladder | 100% | 2576.95 | 21 / 21 | 96% | 94.78 | 482 / 504 |
lung | 99% | 1736.65 | 573 / 578 | 96% | 77.31 | 1113 / 1155 |
esophagus | 100% | 1904.54 | 1441 / 1445 | 91% | 63.81 | 167 / 183 |
stomach | 98% | 1209.49 | 353 / 359 | 88% | 46.86 | 251 / 286 |
breast | 99% | 1560.90 | 455 / 459 | 86% | 36.68 | 964 / 1118 |
intestine | 100% | 2406.90 | 964 / 966 | 85% | 41.16 | 446 / 527 |
prostate | 99% | 2506.11 | 243 / 245 | 73% | 28.93 | 368 / 502 |
kidney | 78% | 710.49 | 69 / 89 | 87% | 68.16 | 787 / 901 |
pancreas | 42% | 253.35 | 138 / 328 | 94% | 56.59 | 167 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 109.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 192.55 | 29 / 29 |
peripheral blood | 100% | 5415.65 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 4086.70 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.00 | 1 / 1 |
adipose | 100% | 1660.10 | 1199 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 144.03 | 44 / 45 |
heart | 95% | 1470.72 | 819 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 1364.19 | 1263 / 1335 | 0% | 0 | 0 / 0 |
brain | 11% | 66.66 | 291 / 2642 | 57% | 24.62 | 405 / 705 |
liver | 11% | 63.68 | 25 / 226 | 25% | 11.80 | 101 / 406 |
muscle | 7% | 38.39 | 57 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010526 | Biological process | retrotransposon silencing |
GO_0051607 | Biological process | defense response to virus |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0016554 | Biological process | cytidine to uridine editing |
GO_0044355 | Biological process | clearance of foreign intracellular DNA |
GO_0070383 | Biological process | DNA cytosine deamination |
GO_0009972 | Biological process | cytidine deamination |
GO_0044029 | Biological process | positive regulation of gene expression via chromosomal CpG island demethylation |
GO_0045087 | Biological process | innate immune response |
GO_0000932 | Cellular component | P-body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004126 | Molecular function | cytidine deaminase activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | APOBEC3C |
Protein name | Apolipoprotein B mRNA editing enzyme catalytic subunit 3C Apolipoprotein B editing enzyme catalytic polypeptide-like 3C DNA dC->dU-editing enzyme APOBEC-3C (A3C) (EC 3.5.4.38) (APOBEC1-like) (Phorbolin I) |
Synonyms | PBI APOBEC1L |
Description | FUNCTION: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity against simian immunodeficiency virus (SIV), hepatitis B virus (HBV), herpes simplex virus 1 (HHV-1) and Epstein-Barr virus (EBV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation. . |
Accessions | ENST00000361441.5 ENST00000428892.1 Q9NRW3 F8WB92 M4VP52 |